等待開盤 03-26 09:30:00 美东时间
+48.100
+4.83%
今日重点评级关注:Guggenheim:维持Cabaletta Bio"买入"评级,目标价从15美元升至16美元;HC Wainwright & Co.:维持Palvella Therapeutics"买入"评级,目标价从255美元升至270美元
03-25 10:31
Baird analyst Jeffrey Meuler maintains Fair Isaac (NYSE:FICO) with a Outperform and lowers the price target from $1960 to $1547.
03-25 01:40
Sen. Josh Hawley launched a probe into Fair Isaac Corp over the company's pricing of credit scoring in the mortgage market.
03-24 20:15
Sen. Josh Hawley (R-MO) sent a letter Monday to Fair Isaac (FICO), disclosing his intention to investigate the company's price increases of its FICO credit scores used widely in the mortgage lending ...
03-24 04:15
FICO reports UK credit card spending falls 9.4% to GBP 755 in January 2026 FICO’s UK credit card market analysis said average spending fell 9.4% month-on-month to GBP 755 and was 1.8% lower than the prior year. Average balances declined 0.6% month-on-month but were 4.8% higher year-on-year. Overall,
03-23 17:00
An update from Fair Isaac ( ($FICO) ) is now available. On March 20, 2026, Fair...
03-21 05:49
今日重点评级关注:花旗:维持Candel Therapeutics"买入"评级,目标价从22美元升至26美元;Chardan Capital:维持CervoMed"买入"评级,目标价从15美元升至21美元
03-19 14:31
与诺和诺德“世纪大和解”!Hims周内暴涨超57%;近十年日企赴美最大IPO,PayPay上市两日涨超32%;获英伟达20亿美元投资,Nebius周涨超26%>>
03-14 10:29
今日重点评级关注:LUCID CAPITAL MARKETS:上调INmune Bio评级至"买入" 目标价从2美元升至9美元;Clear Street:维持MoonLake Immunotherapeutics Class A"买入"评级,目标价从45美元升至70美元
03-12 12:34
UBS analyst Kevin Mcveigh maintains Fair Isaac (NYSE:FICO) with a Neutral and lowers the price target from $1500 to $1350.
03-12 04:13